Biodexa Pharmaceuticals-ADRBDRX
13F holders, Q1 2026 (March 31)1holders
$0.62avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Biodexa Pharmaceuticals-ADR (BDRX) in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($93).
- Company
- Biodexa Pharmaceuticals-ADR
- CUSIP
- 59564R872
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $93 |
| Exits | 0 | $0 |
Ownership 1 holders
| SBI Securities Co., Ltd. | 0.00% | New | 151 | $93 |
"% of holder's portfolio" is BDRX's weight in each manager's 13F, not the share of Biodexa Pharmaceuticals-ADR the manager owns.